📽️ 1, 2, 3... Action! 📽️This is PER — as told by the people who lived it. Hear from some of our attendees on what the PER experience truly means to them. Learn more about what PER has to offer by visiting https://t.co/5xyYscoTbs #gotoPER#testimonialtuesday
KRAS used to mean limited options. Not anymore.
Join @GIcancerDoc, @EileenMOReilly, @BasselElRayesMD, @CentralParkWMD & Dr. Strickler at ISGIO's Spotlight CE Session: Precision Pathways in RAS-Mutant GI Malignancies.
📅Oct 2–3 📍Ft. Lauderdale & Virtual https://t.co/hOi9Xn9KGM
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways from Limited-Stage Through Relapsed Disease https://t.co/df592xgw7p
This will be absolutely a fun 🤩 event.
Looking forward to interactive and insightful discussions 🎙️with the KOLs 👑 who shape this field in K/RAS 🧬 field!
Happy 😆 to join Toni @GIcancerDoc Eileen @EileenMOReilly and John Strickler 👏
KRAS-mutant GI malignancies are one of the fastest-moving areas in oncology right now.
Let’s dig into the biology, the evolving treatment landscape, and real-world case discussions with colleagues at our 2026 ISGIO Spotlight CE Session: Precision Pathways in RAS-Mutant GI Malignancies.
Bring your toughest questions (don’t be kind. @GIcancerDoc will take it 🤣) and we will talk through it together. I hope to see you there October 2-3! Register with code PARK for free registration: https://t.co/V3c1IjJ7xl
#GRIT #PancreaticCancer #GIcancers #RAS #KRAS #biliarycancer #coloncancer #appendicealcancer
Biomarker testing, targeted therapy toxicities, patient expectations — the nursing role in NSCLC care, covered in one session.
Learn more & earn free CME: https://t.co/NodpzBhE0L
#MeetPERinNOLA ⚜️
Show Me the Data™: Emerging Evidence and Evolving Clinical Practice in ET and PV
Join @MKremyanskaya , @drpharrington & @pankitvachhani on risk, cytoreduction & long-term care.
📅 Dec 11 | 📍 New Orleans
See the full NOLA lineup: https://t.co/6LuCIRygYl
How are you navigating immunotherapy decisions across the continuum of hepatobiliary cancer? We’ll be digging into the latest data and real-world clinical decision points in HCC and BTC in Denver this November. Join us! https://t.co/GsMfq3aI7b
Next-gen endocrine agents are reshaping HR+/HER2– breast cancer care.
Explore strategies beyond post-CDK4/6i progression, including frontline use, oral SERDs, and emerging PROTAC data in this free CME activity: https://t.co/QEXlUjY8OD
On the 25th anniversary of 9/11 we pause to remember and honor the lives lost and forever changed that day.
25 years later, we remember. We honor. We will never forget. #NeverForget
💜This Gynecologic Cancer Awareness Month, consider this your sign to stay informed. Join us at the 18th Annual International Symposium on Gynecologic Malignancies® on May 1, 2027, Register now and stay at the forefront of gynecologic oncology education. https://t.co/y4KDUbigRI
Trade the cold for sunshine January 15-17. ☀️
Join leading voices in urology for expert insights, candid conversations, and the latest advances in urologic care, all from Miami Beach! 🌴
50% off registration through November 14, 2026.👉 https://t.co/M064TiLa2A
@dsui_miami_uro
Oncology nurses: Join us in NYC for the 10th Annual School of Nursing Oncology™ on Nov 11. Expert-led sessions, case discussions, and more. Register for just $35! https://t.co/Rj1zcyG15o
#SONO26#OncologyNursing#NursingEducation#NYC